Blueprint Medicines Corp (BPMC)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 8.37B
P/E Ratio
0.00
Revenue (TTM)
$ 562.12M
Volume
0
52W High
$ 129.65
52W Low
$ 73.04
Dividend Yield
0.00%
Beta
0.83
Technicals
50-Day MA
120.0188
200-Day MA
100.2155
52 Week High
129.65
52 Week Low
73.04
About BPMC
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing.
Employees
682
Headquarters
Cambridge, MA
CEO
Ms. Kathryn Haviland M.B.A.